NCT02903030View on ClinicalTrials.gov

Probiotics for Quality of Life in Autism Spectrum Disorders

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

December 1, 2017

Study Completion Date

December 1, 2017

Conditions
Autism Spectrum DisordersAnxiety
Interventions
DRUG

Maltose (placebo)

Maltose with a trace amount of silicon dioxide

DRUG

Visbiome Extra Strength

It is a mix of 8 strains of beneficial bacteria that should improve gut flora, improving GI function and hopefully anxiety

Trial Locations (1)

43210

Ohio State University Wexner Medical Center, Columbus

All Listed Sponsors
collaborator

Autism Treatment Network

NETWORK

collaborator

Autism Speaks

OTHER

lead

Ohio State University

OTHER

NCT02903030 - Probiotics for Quality of Life in Autism Spectrum Disorders | Biotech Hunter | Biotech Hunter